Madrigal Pharmaceuticals, Inc. MDGL Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s short-term investments?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported short-term investments of $585.74M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s short-term investments changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s short-term investments decreased by 11.2% year-over-year, from $659.42M to $585.74M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s short-term investments has grown at a 27.8% compound annual growth rate (CAGR), from $230.15M to $784.87M.
- What does short-term investments mean?
- Financial investments that the company expects to convert into cash within one year.
- How do you interpret short-term investments?
- An increase reflects a conservative treasury strategy to preserve capital, while a decrease may indicate the liquidation of assets to fund operations.
- How does short-term investments compare across companies?
- Standard for companies with large cash reserves seeking to mitigate inflation risk while maintaining liquidity.